Related Experiment Videos
Correction to "Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular
ACS Medicinal Chemistry Letters
|June 22, 2019
Abstract:
[This corrects the article DOI: 10.1021/acsmedchemlett.8b00287.].
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
An ABCB11 variant registry and novel knockin mouse model of PFIC2 based on the clinically relevant ABCB11 E297G variant.
Journal of lipid research·2025
ModBind, a Rapid Simulation-Based Predictor of Ligand Binding and Off-Rates.
Journal of chemical information and modeling·2024
A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation.
The journal of allergy and clinical immunology. Global·2024
Novel Compounds with Aryl Linkers as Glucagon Receptor Agonists for Treating Type 2 Diabetes Mellitus and Obesity.
ACS medicinal chemistry letters·2026
The Great Potential of the Cluster of Differentiation 38 (CD38) Inhibitors in the Treatment of Cancer and Age-Related Metabolic dysfunction.
ACS medicinal chemistry letters·2026
Discovery of CTX-439: A Potent and Selective CDK12 Inhibitor as a Prospective Anti-Cancer Drug.
ACS medicinal chemistry letters·2026
Optimization of Pyrazole-Based Activators of Kv3.1.
ACS medicinal chemistry letters·2026
Identification of Clofibric Acid as a Synoviolin (SYVN1) Ligand for Proteolysis-Targeting Chimera (PROTAC) Development.
ACS medicinal chemistry letters·2026
Probe and Assay Dependent Pharmacology of Dantrolene Analogues at the GPR35.
ACS medicinal chemistry letters·2026
Toward engineered microbial chassis for growth-production balancing.
Synthetic and systems biotechnology·2026
Carboxymethyl cellulose regulated solvation structures enabling long cyclability in aqueous calcium-ion battery.
International journal of biological macromolecules·2026
Untargeted serum lipidomics reveals lipid metabolic disturbances and identifies candidate lipid biomarkers in acute diquat poisoning.
Toxicology and applied pharmacology·2026